JugloneはMMP-1を標的とし,胃がんの進行を抑制する
Fanghui Zhou1, Yi Xie2, Xuelian Li2
1School of Clinical Medicine, Guizhou Medical University, Guiyang, Guizhou, China; Department of Gastroenterology, Qiandongnan Miao and Dong Autonomous Prefecture People's Hospital, Kaili, Guizhou, China.
Biochemical pharmacology
|August 30, 2025
まとめ
ジャグロンは天然の化合物で 胃がんの成長,転移,侵入を効果的に抑制し 化学療法に対する感受性を高めます この研究は,ガストリックがんの治療に 最小限の毒性を持つ有望な天然製品としてJugloneを強調しています.
科学分野:
- 腫瘍学
- 自然製品 化学
- バイオ情報学
背景:
- 胃がんの発生率は上昇しており 薬剤耐性や化学療法による副作用により 進行段階では治療が困難です
- 胃がんの新たな治療戦略の開発は極めて重要で,天然製品は抗がん効果を示しています.
研究 の 目的:
- 胃がん細胞に対するJugloneの抗癌効果と分子メカニズムを調査する.
- 胃がんの前臨床モデルにおけるJugloneの有効性と安全性を評価する.
主な方法:
- バイオインフォマティック分析
- 胃がん細胞のインビトロ細胞実験
- インビヴォ動物モデル
- 増殖,移動,侵入,アポトーシス,細胞サイクル,毒性の評価
主要な成果:
- Jugloneは,胃がん細胞の増殖,移動,侵入,および上皮- 中間酵素の移行を有意に抑制しました.
- 胃がん細胞におけるアポトーシスおよび細胞サイクル停止が誘発され,正常な組織に対する毒性は最小限であった.
- Jugloneは癌細胞の糖分分解経路を妨害し,シスプラチン化学療法に対する感受性を高めました.
結論:
- ジャグロンは,糖分分解経路の障害を含む複数のメカニズムを通じて,強力な胃がん対策を現しています.
- ジグロンはシスプラチン化学療法の有効性を高め,潜在的な併用療法を示唆しています.
- ジャグロンは新しい胃がん治療の開発に 有望な天然製品です
関連する概念動画
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
595
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
595
Peptic Ulcer Disease II: Pathophysiology
827
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
827
Gastritis-II: Pathophysiology
542
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
542
Mucosal Barrier of the Stomach
829
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
829
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Role of Matrix Metalloproteases in Degradation of ECM
2.5K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.5K

